Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

SECC Scottish Exhibition and Conference Centre

Mar 29, 2017 9:00 AM - Mar 31, 2017 5:30 PM

Exhibition Way, Glasgow, G3 8YW, United Kingdom

29th Annual EuroMeeting

The EuroMeeting provides experts from all disciplines of healthcare product development a platform to debate and find solutions to the challenges of an ever-evolving healthcare system.

Major Regulatory Challenges Enabling Decision Making for Early Patient Access: Regulatory Tools and Sources of RWE

Session Chair(s)

Karl  Broich, DrMed

Karl Broich, DrMed

President

Federal Institute for Drugs and Medical Devices (BfArM), Germany

Joseph  Scheeren, PharmD

Joseph Scheeren, PharmD

Founder

Scheeren HealthCare LLC, United States

The commitment for enabling early patient access to new innovative medicines is one of the major challenges in regulatory science. From a regulator’s perspective, early access tools are in place in the EU and the US in order to support early approval. In addition, real world evidence (RWE) presents a significant opportunity to improve regulatory decision making. Technological advances permit collection of real world data (RWD) from an increasing number of sources like patient registries and electronic patient records etc., while new artificial Intelligence approaches permit to translate these data into RWE. This cross functional DIAmond session will discuss opportunities and challenges from the regulator (EU and US), industry and patient perspective.

Learning Objective : • Understand the challenges of establishing a patient registry in an ultra-orphan disease area • Understand steps that can be taken to create larger and richer registries • Develop a perspective on how best to work with industry partners who want to support registry efforts

Speaker(s)

Tomas  Salmonson, DrMed, PhD

Early Access to Medicines in the EU - Regulatory Tools and Challenges in the Context of Other Regions

Tomas Salmonson, DrMed, PhD

Critical Path Institute, United States

Partner

Sandra  Kweder, MD

Current Status and Challenges of Early Access Tools and the Opportunities of Real-World Evidence (RWE) for Regulatory Decision Making in the US

Sandra Kweder, MD

Greenleaf Health/Elilquent, United States

Principal, Drug and Biological Products

Badri  Rengarajan, MD

Major Challenges for Industry and Opportunities for Real World Data Generation Including Patient Registry to Enable Regulatory Decision Making

Badri Rengarajan, MD

Jazz Pharmaceuticals, United States

Life Sciences

Elizabeth  Vroom

Panel Discussion

Elizabeth Vroom

Duchenne Parent Project, Netherlands

President

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.